Biology Expert Witnesses in West Virginia

This renowned expert is currently the Chair of the department of Family and Geriatric Medicine for a major university in Kentucky, where she also works as a Professor of Obstetrics & Gynecology, Bioengineering, Epidemiology & Population Health, and Health Promotion and Behavioral Sciences. The expert specializes in human papillomavirus and its associated diseases, as well as colposcopy. She acted as the Principal Investigator of the clinical trials for leading HPV vaccines Gardasil and Cervarix. The expert has appeared frequently in national outlets commenting on the safety and efficacy of HPV vaccines. He has a B.S. in Chemical Engineering and an M.S. in Polymerics from M.I.T., as well as an M.D. and an M.P.H. in Biostatistics & Epidemiology from the University of Kansas Medical School. The expert is board certified by the American Board of Family Practice and is licensed to practice in Missouri, Kansas, New Hampshire, Vermont, and Kentucky.

This highly qualified expert has extensive experience in the fields of cancer, biomedical research, pre-clinical animal research and ethics, and drug development, among others. After earning his BS from East Carolina University and his MS from The University of North Carolina at Greensboro, this expert completed his PhD in genetics and molecular biology at The University of North Carolina, Chapel Hill. He also went on to complete his MBA in biosciences management at North Carolina State University. This expert is an active member of the American Association of Immunologists, the Society for Leukocyte Biology, and the American Association for Cancer Research. In addition to being extensively published, he is the current associate editor of Frontiers in Immunology and Frontiers in Microbiology. Further, this expert has been engaged in a variety of university program development and research operations leadership roles throughout his career. Among his former roles, he has served as a research analyst with the Center for Human Genetics at Duke University Medical Center, a research associate for microbiology and immunology at The University of North Carolina Chapel Hill, and as an assistant professor of inflammatory diseases at Virginia-Maryland College of Veterinary Medicine. This expert currently maintains two assistant professorships at a public medical school in Virginia, in addition to his primary role as an associate professor of inflammatory diseases at a veterinary medicine education school.

This highly qualified expert is specialized in the color and cosmetics chemistry with a deep understanding of formulation, toxicology, microbiology, and the safety requirements of products within his field. He spent 34 years with the Food and Drug Administration where he held a number of positions including serving as the chief of color technology, deputy director of color and cosmetics, and director of applied research and safety assessment at CFSAN. He also served as the director of cosmetic chemistry at The Cosmetic, Toiletry and Fragrance Association and as the executive vice president of science at The Personal Care Products Council. Currently, this expert is an independent advisor of a consulting group in Virginia.

This highly-qualified laryngology expert has experience with voice and airway disorders, laryngeal and airway trauma, difficult airways, and vocal fold paralysis. She received her BSE in mechanical engineering from the Pratt School of Engineering at Duke University and her MSE in mechanical engineering from the University of Michigan before earning her MD from Wayne State University. She subsequently completed her residency in otolaryngology with a focus in head and neck surgery at Henry Ford Health System and her fellowship in voice and airway surgery at the Cleveland Clinic Foundation. This expert is board-certified in otolaryngology and is active in her field as a member of the American Academy of Otolaryngology-Head and Neck Surgery, the International Association of Phonosurgeons, and the Triological Society. Formerly, she served as a global product development engineer at General Motors Corporation, an assistant professor of immunology & microbiology at Wayne State University School of Medicine, an assistant professor of otolaryngology at Oakland School of Medicine, and a locum tenens otolaryngologist at ProMedica Memorial Hospital. Currently, this expert serves as a staff laryngologist at a health network, as well as an assistant professor of surgery in otolaryngology at a university, both in Pennsylvania.

This highly qualified expert currently serves as Assistant Professor of Pediatrics and Affiliate Faculty of the Molecular Genetics Department at a major medical university. In addition to a Ph.D. in Cell Biology from Duke University Medical Center, he received a B.S. in Physiology and Neurobiology and a M.S. in Developmental Neurobiology from the University of Maryland. A member of both the Society for Developmental Biology and the American Society for Human Genetics, he has authored several publications on developmental biology. He has over 15 years of experience in the genetics of congenital defects.

A 17-year veteran of the U.S. Food and Drug Administration (FDA), this expert served as the Regulatory Counsel to the Associate Commissioner for Regulatory Affairs, and previously, in scientific, inspectional, compliance and criminal and civil enforcement capacities as an FDA Consumer Safety Officer (CSO), Compliance Officer (CO), a Senior Special Agent (SA) with the Office of Criminal Investigations (OCI) and as an analytical regulatory microbiologist. During his last three years at FDA he spearheaded the agency's integration efforts with Customs and USDA on crosscutting interagency enforcement and operational issues; served as the FDA's point-person in managing the intersection of imports and FDA's new bioterrorism regulations; established joint agency and industry working groups to evaluate counterfeiting and tampering risks to food and drug distribution supply chains; was the agency lead in its strategic planning efforts to reinvent the FDA's import programs; wrote the initial statement of work and acted as program manager over the FDA's new PREDICT, risk-based electronic entry screening system; and directed the development of the FDA's agency-wide Risk-based Import Strategic Plan designed to improve compliance of foods, dietary supplements, drugs, medical devices, cosmetics, and biological products imported into the U.S. As CEO of a FDA consulting firm and Founder of an affiliated law firm, he currently represents domestic and foreign companies of all sizes, assisting them in identifying USDA, FDA, Federal Trade Commission (FTC), Environmental Protection Agency (EPA), and state requirements. He focuses his practice on FDA matters, including but not limited to: matters relating to FDA inspections, FDA criminal, regulatory and administrative enforcement actions for medical devices, drugs, cosmetics, alcohol, tobacco, dietary supplements, and foods.